China Health Group Inc. (8225.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap130.53M
Enterprise Value107.09M
P/E Ratio-3.1
PEG Ratio0.04
Price/Sales Ratio2.56
Price/Book Ratio1.48
Enterprise/Revenue1.83
Enterprise/EBITDA-17.99

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-0.46
Operating Margin0.12
AD

Management Effectiveness

Return On Assets-0.17
Return On Equity-0.22

Income Statement

Revenue27.82M
Revenue/Share0.03
Gross Profit15.97M
EBITDA-14.05M
Net Income-14.57M
Diluted EPS-0.01

Balance Sheet

Total Cash25.16M
Total Cash/Share0.03
Total Debt0
Total Debt/Equity0
Current Ratio2.17
Book Value Per Share0.05

Price History

52-Week Change-44.12
52-Week High0.2
52-Week Low0.09
Moving Average 50 Days0.12
Moving Average 200 Days0.14

Statistics

Average Volume91,147
Shares Outstanding995.35M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor747:500
Last Split DateOctober 13, 2014
AD